Results 11 to 20 of about 117,235 (282)

Spironolactone for heart failure with preserved ejection fraction [PDF]

New England Journal of Medicine, 2014
BACKGROUND: Mineralocorticoid-receptor antagonists improve the prognosis for patients with heart failure and a reduced left ventricular ejection fraction.
Anand, Inder S., Assmann, Susan F., Boineau, Robin, Claggett, Brian, Clausell, Nadine, Desai, Akshay S., Diaz, Rafael, Fleg, Jerome L., Gordeev, Ivan, Harty, Brian, Heitner, John F., Kenwood, Christopher T., Lewis, Eldrin F., McKinlay, Sonja M., O'Meara, Eileen, Pfeffer, Marc A., Pitt, Bertram, Probstfield, Jeffrey L., Shaburishvili, Tamaz, Shah, Sanjiv J., Solomon, Scott D., Sweitzer, Nancy K., TOPCAT Investigators, Ventura, H., Yang, Song   +24 more
core   +3 more sources

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. [PDF]

New England Journal of Medicine, 2015
BACKGROUND: Nitrates are commonly prescribed to enhance activity tolerance in patients with heart failure and a preserved ejection fraction. We compared the effect of isosorbide mononitrate or placebo on daily activity in such patients.
Anstrom, Kevin J., Borlaug, Barry A., Braunwald, Eugene, Chen, Horng H., Cole, Robert T., Felker, G. Michael, Joseph, Susan M., Koepp, Gabe A., Levine, James A., LeWinter, Martin M., McNulty, Steven E., Redfield, Margaret M., Reeves, Gordon R., Semigran, Marc J., Shah, Monica R, Shah, Sanjiv J., Tang, W.H. Wilson, Tedford, Ryan J., Velazquez, Eric J.   +18 more
core   +4 more sources

Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry

Anatolian Journal of Cardiology, 2023
Background: Heart failure with preserved ejection fraction is a complex and heterogeneous clinical syndrome, poses significant diagnostic challenges.
Gurbet Özge Mert, Bülent Özlek, Eda Özlek, Hicaz Zencirkiran Ağuş, Mehmet Tekinalp, Serkan Kahraman, Cem Çil, Oğuzhan Çelik, Özcan Başaran, Volkan Doğan, Bedri Caner Kaya, İbrahim Rencüzoğulları, Altuğ Ösken, Lütfü Bekar, Mustafa Ozan Çakır, Yunus Çelik, Kadriye Memiç Sancar, Samet Sevinç, Murat Biteker, Kadir Uğur Mert   +19 more
doaj   +1 more source

Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction

Frontiers in Immunology, 2022
The incidence of heart failure with preserved ejection fraction is increasing in patients with obesity, diabetes, hypertension, and in the aging population. However, there is a lack of adequate clinical treatment.
Chenyu Li, Donglu Qin, Jiarui Hu, Yang Yang, Die Hu, Bilian Yu   +5 more
doaj   +1 more source

Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review

Терапевтический архив, 2023
Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden.
Igor V. Zhirov, Natalia V. Safronova, Sergey N. Tereshchenko   +2 more
doaj   +1 more source

Managing heart failure with preserved ejection fraction [PDF]

Annals of Translational Medicine, 2020
Heart failure with preserved ejection fraction (HFpEF) is increasing in prevalence as the general population ages. Poorly managed heart failure symptoms of decompensated HFpEF is one of the most common reasons for prolonged hospital admission. The high rate of morbidity and mortality associated with HFpEF is compounded by a poor understanding of the ...
Davidson, Alexander, Raviendran, Nivashinie, Murali, Charisma Nair, Myint, Phyo Kyaw   +3 more
openaire   +3 more sources

Heart Failure With Preserved Ejection Fraction: Defining Phenotypes [PDF]

Journal of Cardiac Failure, 2020
Heart failure with preserved ejection (HFpEF) has been increasingly recognized as an epidemic and various phenotypes have now been suggested.
Donal, Erwan, L'Official, Guillaume, Kosmala, W   +2 more
openaire   +3 more sources

Heart failure with preserved ejection fraction. [PDF]

Journal of geriatric cardiology : JGC, 2013
Progressive aging of the population and prolongation of life expectancy have led to the rising prevalence of heart failure (HF). Despite the improvements in medical therapy, the mortality rate of this condition has remained unacceptably high, becoming the primary cause of death in the elderly population.
Whalley, Gillian, Rigolli, Marzia
openaire   +5 more sources

Heart Failure With Preserved Ejection Fraction

Journal of Osteopathic Medicine, 2015
Abstract Heart failure with preserved ejection fraction (HFpEF) is a complex clinical condition. Initially called diastolic heart failure, it soon became clear that this condition is more than the opposite side of systolic heart failure. It is increasingly prevalent and lethal.
Felix J, Rogers, Teja, Gundala, Jahir E, Ramos, Asif, Serajian   +3 more
openaire   +3 more sources

Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors

Women's Health, 2022
Heart failure with preserved ejection fraction has a higher prevalence in women versus men. There are several proposed mechanisms to explain this sex discrepancy including differences in cardiovascular adaptation to comorbidities and potential underlying
Gurleen Kaur, Emily Lau
doaj   +1 more source